Loading clinical trials...
Loading clinical trials...
A Phase 1b/2 Randomised Placebo Controlled Trial of Fulvestrant +/- AZD5363 in Postmenopausal Women With Advanced Breast Cancer Previously Treated With a Third Generation Aromatase Inhibitor
Conditions
Interventions
AZD5363
Placebo
+1 more
Locations
21
United Kingdom
Velindre NHS Trust
Cardiff, Cardiff, United Kingdom
Christie Hospital
Manchester, Greater Manchester, United Kingdom
Ysbyty Gwynedd
Bangor, United Kingdom
Clatterbridge Cancer Centre
Bebington, United Kingdom
Royal Blackburn Hospital
Blackburn, United Kingdom
Blackpool Victoria Hospital
Blackpool, United Kingdom
Start Date
May 7, 2014
Primary Completion Date
March 1, 2019
Completion Date
December 31, 2025
Last Updated
November 26, 2025
NCT01984138
NCT01996046
NCT00066690
NCT02409316
NCT04727632
NCT02823262
Lead Sponsor
Velindre NHS Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions